Follow
Laura Rosa Mangiapane
Laura Rosa Mangiapane
Unknown affiliation
Verified email at unipa.it
Title
Cited by
Cited by
Year
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
JF Linnekamp, SR Hooff, PR Prasetyanti, R Kandimalla, JY Buikhuisen, ...
Cell Death & Differentiation 25 (3), 616-633, 2018
1812018
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage
E Lo Presti, F Toia, S Oieni, S Buccheri, A Turdo, LR Mangiapane, ...
Cancer Immunology Research 5 (5), 397-407, 2017
692017
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients
F Virzì, P Bianca, A Giammona, T Apuzzo, S Di Franco, LR Mangiapane, ...
Stem cell research & therapy 8, 1-11, 2017
582017
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
LR Mangiapane, A Nicotra, A Turdo, M Gaggianesi, P Bianca, S Di Franco, ...
Gut 71 (1), 119-128, 2022
552022
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
A Petrelli, R Carollo, M Cargnelutti, F Iovino, M Callari, D Cimino, ...
Oncotarget 6 (4), 2315, 2015
502015
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
S Di Franco, P Bianca, DS Sardina, A Turdo, M Gaggianesi, V Veschi, ...
Nature communications 12 (1), 5006, 2021
462021
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
S Di Franco, B Parrino, M Gaggianesi, VD Pantina, P Bianca, A Nicotra, ...
Iscience 24 (6), 2021
332021
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant
V Veschi, LR Mangiapane, A Nicotra, S Di Franco, E Scavo, T Apuzzo, ...
Oncogene 39 (5), 987-1003, 2020
252020
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis
S Di Franco, A Turdo, A Benfante, ML Colorito, M Gaggianesi, T Apuzzo, ...
Oncotarget 7 (34), 54157, 2016
252016
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy
A Turdo, A Glaviano, G Pepe, F Calapà, S Raimondo, ME Fiori, ...
Cancers 13 (16), 3927, 2021
242021
Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids
M Lepore Signorile, V Grossi, S Di Franco, G Forte, V Disciglio, C Fasano, ...
Cell Death & Disease 12 (4), 316, 2021
112021
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
V Veschi, A Turdo, C Modica, F Verona, S Di Franco, M Gaggianesi, ...
Nature Communications 14 (1), 1351, 2023
72023
Dual inhibition of myc transcription and PI3K activity effectively targets colorectal cancer stem cells
M Gaggianesi, LR Mangiapane, C Modica, VD Pantina, G Porcelli, ...
Cancers 14 (3), 673, 2022
42022
Innovative therapeutic strategies targeting colorectal cancer stem cells
A Giammona, LR Mangiapane, S Di Franco, A Benfante, M Todaro, ...
Current Colorectal Cancer Reports 13 (2), 91-100, 2017
42017
Cancer cell targeting by CAR-T cells: A matter of stemness
C D’Accardo, G Porcelli, LR Mangiapane, C Modica, VD Pantina, ...
Frontiers in Molecular Medicine 2, 1055028, 2022
12022
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
SD Franco, P Bianca, DS Sardina, A Turdo, M Gaggianesi, V Veschi, ...
Nature Communications 12 (1), 1-16, 2021
12021
Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
A Petrelli, R Carollo, M Cargnelutti, F Iovino, M Callari, D Cimino, ...
Oncotarget 10 (48), 5003, 2019
12019
SUPPLEMENTAL INFORMATION METHODS CRC sphere cell culture
LR Mangiapane
Gut 119, 71, 2021
2021
A new targeted combination therapy overcomes the acquired resistance of colorectal cancer stem cells
A Benfante, LR Mangiapane, ML Colorito, M Gaggianesi, A Nicotra, ...
European Journal of Cancer 1 (61), S47-S48, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–19